Thromb Haemost 1982; 47(03): 239-243
DOI: 10.1055/s-0038-1657177
Original Article
Schattauer GmbH Stuttgart

Determination of the Density Distribution of Human Platelets - Methodological Aspects and Comparison with Other Tests for Platelet Activation

B A van Oost
The University Hospital Utrecht, Department of Haematology, Utrecht, The Netherlands
,
I H van Hien-Hagg
The University Hospital Utrecht, Department of Haematology, Utrecht, The Netherlands
,
B F E Veldhuyzen
The University Hospital Utrecht, Department of Haematology, Utrecht, The Netherlands
,
A P M Timmermans
The University Hospital Utrecht, Department of Haematology, Utrecht, The Netherlands
,
J J Sixma
The University Hospital Utrecht, Department of Haematology, Utrecht, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 16 October 1981

Accepted 06 April 1982

Publication Date:
13 July 2018 (online)

Summary

Stimulation of human platelets to release results in decreased buoyant density. This decreased density provides a tool to detect circulating platelets which have participated in a thrombotic process. Platelet density gradient centrifugation using Stractan was standardized and the effects of anticoagulation, temperature, and osmolarity were investigated. In 7 out of 32 patients with thrombotic disease less dense platelets were found. Platelet activation in the patient group was also indicated by spontaneous aggregation (10/32), decreased circulating platelet aggregate ratios (5/24) and elevated plasma β-thromboglobulin levels (2/11). Several of these tests were also abnormal in diabetes mellitus thrombocytosis, leukaemia and several systemic diseases with thrombotic complications. The platelet density test using Stractan is reproducible and independent of other tests for platelet activation and is therefore potentially a useful extension of platelet function testing in patients with thrombotic disease.

 
  • References

  • 1 McDonald TP, Odell TT, Gosslee DG. Platelet Size in Relation to Platelet Age. Proc Soc Exp Biol Med 1963; 115: 684-689
  • 2 Pennington DG, Lee NYL, Roxburgh AE, McGready JR. Platelet Density and Size: the Interpretation of Heterogeneity. Br J Haematol 1976; 34: 365-376
  • 3 Corash L, Shafer B, Perlow M. Heterogeneity of Human Whole Blood Platelet Subpopulations. II. Use of a Subhuman Primate Model to Analyze the Relationship Between Density and Platelet Age. Blood 1978; 52: 726-734
  • 4 Cieslar P, Greenberg JP, Rand ML, Packham MA, Kinlough-Rathbone RL, Mustard JF. Separation of Thrombin-Treated Platelets From Normal Platelets by Density-Gradient Centrifugation. Blood 1979; 53: 867-874
  • 5 Corash L, Tan H, Gralnick HR. Heterogeneity of Human Whole Blood Platelet Subpopulations. I. Relationship Between Buoyant Density, Cell Volume, and Ultrastructure. Blood 1977; 49: 71-87
  • 6 Ludlam CA, Cash JD. Studies on the Liberation of β-Thromboglobulin from Human Platelets in Vitro. Br J Haematol 1976; 33: 239-247
  • 7 Wu KK, Hoak JC. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; ii: 924-926
  • 8 Kaplan KL, Nossel HL, Drillings M, Lesznik G. Radioimmunoassay of Platelet Factor 4 and β-Thromboglobulin: Development and Application to Studies of Platelet Release in Relation to Fibrinopeptide A Generation. Br J Haematol 1978; 39: 129-146
  • 9 Mustard JF, Packham MA. Platelet, Thrombosis and Drugs. Drugs 1975; 9: 19-76
  • 10 Baumgartner HR, Muggli R, Tschopp TB, Turitto VT. Platelet Adhesion, Release and Aggregation in Flowing Blood: Effects of Surface Properties and Platelet Function. Thromb Haemostas 1976; 35: 124-138
  • 11 Groves HM, Kinlough-Rathbone RL, Richardson M, Moore S, Mustard JF. Platelet Interaction with Damaged Rabbit Aorta. Lab Invest 1979; 40: 194-200
  • 12 Reimers HJ, Kinglough-Rathbone RL, Cazenave JP, Senyi AF, Hirsh J, Packham MA, Mustard JF. In Vitro and in Vivo Functions of Thrombin-Treated Platelets. Thromb Haemostas 1976; 35: 151-166
  • 13 Boneu B, Corberand J, Plante Y, Bierme R. Evidence that Platelet Density and Volume are not related to Aging. Thromb Res 1977; 10: 475-486
  • 14 Preston FE, Ward ID, Marcola BH, Porter NR, Timperley WR, O’Malley BC. Elevated β-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1978; i: 238-240
  • 15 Schwartz MB, Hawiger J, Timmons S, Friesinger GC. Platelet Aggregates in Ischemic Heart Disease. Thromb Haemostas 1980; 43: 185-188
  • 16 Salem HH, Koutts J, Firkin BG. Circulating platelet aggregates in ischaemic heart disease and their correlation to platelet life span. Thromb Res 1980; 17: 707-711
  • 17 Lowe GDO, Reavey MM, Johnston RV, Forbes CD, Prentice CRM. Increased platelet aggregates in vascular and non-vascular illness: correlation with plasma fibrinogen and effect of ancrod. Thromb Res 1979; 14: 377-386
  • 18 Lowe GDO, Drummond MM, Third JLHC, Bremner WF, Forbes CD, Prentice CRM, Lawrie TDV. Increased Plasma Fibrinogen and Platelet-Aggregates in Type II Hyperlipoproteinaemia. Thromb Haemostas 1979; 42: 1503-1507
  • 19 Dougherty JH, Levy DE, Weksler BB. Platelet Activation in Acute Cerebral Ischaemia. Lancet 1977; i: 821-824
  • 20 Prazich JA, Rapaport SI, Samples JR, Engler R. Platelet Aggregate Ratios-Standardization of Technique and Test Results in Patients with Myocardial Ischaemia and Patients with Cerebrovascular Disease. Thromb Haemostas 1977; 38: 597-605
  • 21 Ten Cate JW, Vos J, Oosterhuis H, Prenger D, Jenkins CSP. Spontaneous Platelet Aggregation in Cerebrovascular Disease. Thromb Haemostas 1978; 39: 223-229
  • 22 Hoogendijk EMG, Jenkins CSP, van Wijk EM, Vos J, ten Cate JW. Spontaneous Platelet Aggregation in Cerebrovascular Disease II. Further Characterisation of the Platelet Defect. Thromb Haemostas 1979; 41: 512-522
  • 23 Hoogendijk EMG. Platelets in cerebrovascular disease. Thesis Amsterdam: 1980
  • 24 Chen YC, Wu KK. A Comparison of Methods for the Study of Platelet Hyperfunction in Thrombeombolic Disorders. Br J Haematol 1980; 46: 263-268
  • 25 O’Malley BC, Timperley WR, Ward JD, Porter NR, Preston FE. Platelet abnormalities in diabetic peripheral neuropathy. Lancet 1975; ii: 1274-1276
  • 26 Zahavi J, Kakkar VV. β-Thromboglobulin – a Specific Marker of In Vivo Platelet Release Reaction. Thromb Haemostas 1980; 44: 23-29
  • 27 Vreeken J, van Aken WG. Spontaneous aggregation of blood platelets as a cause of idiopathic thrombosis and recurrent painful toes and fingers. Lancet 1971; ii: 1394-1397
  • 28 Boughton BJ, Allington MJ, King A. Platelet and Plasma β-Thromboglobulin in Myeloproliferative Syndromes and Secondary Thrombocytosis. Br J Haematol 1978; 40: 125-132
  • 29 Wu K. Platelet Hyperaggregability and Thrombosis in Patients with Thrombocythemia. Ann Intern Med 1978; 88: 7-11
  • 30 Cortelazzo S, Viero P, Barbui T. Platelet Activation in Myeloproliferative Disorders. Thromb Haemostas 1981; 45: 211-213
  • 31 Wu KK, Hoak JC. Increased Platelet Aggregates in Patients with Transient Ischemic Attacks. Stroke 1975; 6: 521-524
  • 32 Cella G, Zahavi J, de Haas HA, Kakkar VV. β-Thromboglobulin, Platelet Production Time and Platelet Function in Vascular Disease. Br J Haematol 1979; 43: 127-136
  • 33 Wu KK, Hoak JC. Spontaneous Platelet Aggregation in Arterial Insufficiency: Mechanisms and Implications. Thromb Haemostas 1976; 35: 702-711